acumapimod   Click here for help

GtoPdb Ligand ID: 9203

Synonyms: BCT 197 | BCT-197 | BCT197 | compound A [WO2013139809]
Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: Acumapimod (BCT-197) is an orally active p38 mitogen activated protein kinase inhibitor with potential anti-inflammatory action. This compound is claimed in patent WO2013139809 [1] and in patent WO2005009973 as EXAMPLE 52 [2].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 2
Rotatable bonds 6
Topological polar surface area 113.28
Molecular weight 385.15
XLogP 3.64
No. Lipinski's rules broken 0
Click here for help
Canonical SMILES N#Cc1cccc(c1)C(=O)c1cnn(c1N)c1cc(ccc1C)C(=O)NC1CC1
Isomeric SMILES N#Cc1cccc(c1)C(=O)c1cnn(c1N)c1cc(ccc1C)C(=O)NC1CC1
InChI InChI=1S/C22H19N5O2/c1-13-5-6-16(22(29)26-17-7-8-17)10-19(13)27-21(24)18(12-25-27)20(28)15-4-2-3-14(9-15)11-23/h2-6,9-10,12,17H,7-8,24H2,1H3,(H,26,29)
1. Ford PA. (2013)
Use of a pyrazole derivative in the treatment of acute exacerbations of chronic obstructive pulmonary disease.
Patent number: WO2013139809. Assignee: Novartis Ag. Priority date: 20/03/2012. Publication date: 26/09/2013.
2. Fryszman OM, Lang H, Lan J, Chang E, Fang Y. (2005)
5-membered heterocycle-based p38 kinase inhibitors.
Patent number: WO2005009973. Assignee: Novartis Ag. Priority date: 26/06/2003. Publication date: 03/02/2005.